Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,52k | 0,80% |
| 2026-05-28 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 130,06k | Verkauf | 130,06 | 639,00 | -61,01% |
| 2026-05-27 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -10,00k | 1,25M | Verkauf | 125,08 - 126,08 | 35,95k | -21,76% |
| 2026-05-22 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -24,41k | 2,09M | Derivative Exercise and Sale | 32,86 - 118,67 | 60,03k | - |
| 2026-05-20 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -20,00k | 2,13M | Verkauf | 105,34 - 107,23 | 45,95k | -30,33% |
| 2026-05-20 | Dr. AmirAli TalasazCo-CEO & Director | -210,00k | 23,08M | Verkauf | 100,95 - 112,76 | 1,89M | -10,02% |
| 2026-05-20 | Dr. Manuel Hidalgo MedinaIndependent Director | -250,00 | 26,77k | Verkauf | 107,07 | 1,64k | -13,23% |
| 2026-05-20 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 74,55k | Derivative Exercise and Sale | 32,55 - 107,10 | 1,64k | - |
| 2026-05-20 | Mr. Ian T. ClarkLead Independent Director | -6,88k | 735,05k | Verkauf | 106,90 | 2,98k | -69,80% |
| 2026-05-15 | Mr. Musa TariqIndependent Director | -116,00 | 11,13k | Derivative Exercise and Sale | 95,96 | 8,66k | - |
| 2026-05-15 | Mr. Musa TariqIndependent Director | 134,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,66k | 1,57% |
| 2026-05-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,89k | 14,00% |
| 2026-05-15 | Dr. Darya ChudovaCTO | -4,68k | 444,13k | Derivative Exercise and Sale | 94,92 | 83,94k | - |
| 2026-05-15 | Dr. Darya ChudovaCTO | 4,03k | 0,00 | Derivative Exercise and Retained Stock | - | 83,94k | 5,04% |
| 2026-05-12 | Dr. AmirAli TalasazCo-CEO & Director | -50,00k | 5,02M | Verkauf | 100,32 | 2,10M | -2,33% |
| 2026-04-30 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,36k | 0,80% |
| 2026-04-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,75k | 5,88% |
| 2026-04-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,66k | 16,28% |
| 2026-04-15 | Mr. Musa TariqIndependent Director | 134,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,53k | 1,60% |
| 2026-04-15 | Mr. Musa TariqIndependent Director | -116,00 | 9,84k | Derivative Exercise and Sale | 84,83 | 8,53k | - |
| 2026-04-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 3,60k | 0,00 | Derivative Exercise and Retained Stock | - | 65,95k | 5,77% |
| 2026-04-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -3,97k | 336,89k | Derivative Exercise and Sale | 84,86 | 65,95k | - |
| 2026-04-06 | Ms. Terilyn Juarez MonroeCPO | -3,83k | 355,15k | Verkauf | 92,68 | 20,99k | -15,44% |
| 2026-04-01 | Ms. Terilyn Juarez MonroeCPO | 3,83k | 0,00 | Derivative Exercise and Retained Stock | - | 24,82k | 18,26% |
| 2026-04-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 5,45k | 0,00 | Derivative Exercise and Retained Stock | - | 62,35k | 9,57% |
| 2026-04-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -6,01k | 548,08k | Derivative Exercise and Sale | 91,15 | 62,35k | - |
| 2026-04-01 | Ms. Terilyn Juarez MonroeCPO | -4,19k | 381,65k | Derivative Exercise and Sale | 91,15 | 24,82k | - |
| 2026-04-01 | Mr. Kumud KaliaChief Information Officer | 4,95k | 0,00 | Derivative Exercise and Retained Stock | - | 49,25k | 11,18% |
| 2026-04-01 | Mr. Kumud KaliaChief Information Officer | -5,09k | 464,14k | Derivative Exercise and Sale | 91,15 | 49,25k | - |
| 2026-04-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 6,46k | 0,00 | Derivative Exercise and Retained Stock | - | 60,03k | 12,06% |
| 2026-04-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -4,75k | 432,96k | Derivative Exercise and Sale | 91,15 | 60,03k | - |
| 2026-04-01 | Dr. Craig EagleInsider | 5,62k | 0,00 | Derivative Exercise and Retained Stock | - | 72,00k | 8,47% |
| 2026-04-01 | Dr. Craig EagleInsider | -5,78k | 526,76k | Derivative Exercise and Sale | 91,15 | 72,00k | - |
| 2026-04-01 | Mr. Michael BellCFO | 5,91k | 0,00 | Derivative Exercise and Retained Stock | - | 49,51k | 13,55% |
| 2026-04-01 | Mr. Michael BellCFO | -6,87k | 626,11k | Derivative Exercise and Sale | 91,15 | 49,51k | - |
| 2026-04-01 | Dr. Darya ChudovaCTO | 6,02k | 0,00 | Derivative Exercise and Retained Stock | - | 79,91k | 8,15% |
| 2026-04-01 | Dr. Darya ChudovaCTO | -7,01k | 638,51k | Derivative Exercise and Sale | 91,15 | 79,91k | - |
| 2026-03-31 | Dr. AmirAli TalasazCo-CEO & Director | 18,02k | 0,00 | Derivative Exercise and Retained Stock | - | 2,48M | 0,73% |
| 2026-03-31 | Dr. AmirAli TalasazCo-CEO & Director | -18,52k | 1,69M | Derivative Exercise and Sale | 91,15 - 92,37 | 2,48M | - |
| 2026-03-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 18,02k | 0,00 | Derivative Exercise and Retained Stock | - | 2,44M | 0,74% |
| 2026-03-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -18,52k | 1,69M | Derivative Exercise and Sale | 91,15 - 92,37 | 2,44M | - |
| 2026-03-31 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,21k | 0,81% |
| 2026-03-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,49k | 6,25% |
| 2026-03-18 | Mr. Musa TariqIndependent Director | -348,00 | 30,66k | Verkauf | 88,09 | 8,39k | -3,98% |
| 2026-03-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,43k | 19,45% |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 32,18k | 0,00 | Derivative Exercise and Retained Stock | - | 2,42M | 1,35% |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -33,07k | 3,15M | Derivative Exercise and Sale | 85,49 - 102,14 | 2,42M | - |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -13,21k | 0,00 | Other Disposition | - | 2,42M | -0,54% |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | 32,18k | 0,00 | Derivative Exercise and Retained Stock | - | 2,46M | 1,32% |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | -33,07k | 3,15M | Derivative Exercise and Sale | 85,49 - 102,14 | 2,46M | - |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | -13,21k | 0,00 | Other Disposition | - | 2,46M | -0,53% |
| 2026-03-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 4,19k | 0,00 | Derivative Exercise and Retained Stock | - | 56,90k | 7,95% |
| 2026-03-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -4,62k | 395,13k | Derivative Exercise and Sale | 85,49 | 56,90k | - |
| 2026-03-15 | Mr. Kumud KaliaChief Information Officer | 6,65k | 0,00 | Derivative Exercise and Retained Stock | - | 44,30k | 17,68% |
| 2026-03-15 | Mr. Kumud KaliaChief Information Officer | -6,84k | 584,67k | Derivative Exercise and Sale | 85,49 | 44,30k | - |
| 2026-03-15 | Mr. Musa TariqIndependent Director | 249,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,74k | 2,93% |
| 2026-03-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 9,70k | 0,00 | Derivative Exercise and Retained Stock | - | 53,57k | 22,11% |
| 2026-03-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -7,13k | 609,29k | Derivative Exercise and Sale | 85,49 | 53,57k | - |
| 2026-03-15 | Dr. Craig EagleInsider | 7,45k | 0,00 | Derivative Exercise and Retained Stock | - | 66,38k | 12,65% |
| 2026-03-15 | Dr. Craig EagleInsider | -7,66k | 654,94k | Derivative Exercise and Sale | 85,49 | 66,38k | - |
| 2026-03-15 | Dr. Darya ChudovaCTO | 4,96k | 0,00 | Derivative Exercise and Retained Stock | - | 73,89k | 7,19% |
| 2026-03-15 | Dr. Darya ChudovaCTO | -5,76k | 492,34k | Derivative Exercise and Sale | 85,49 | 73,89k | - |
| 2026-03-15 | Mr. Michael BellCFO | 3,38k | 0,00 | Derivative Exercise and Retained Stock | - | 43,60k | 8,40% |
| 2026-03-15 | Mr. Michael BellCFO | -10,41k | 894,85k | Derivative Exercise and Sale | 85,49 - 87,04 | 43,60k | - |
| 2026-03-06 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 59,06k | Derivative Exercise and Sale | 32,55 - 91,61 | 1,19k | - |
| 2026-03-06 | Dr. Manuel Hidalgo MedinaIndependent Director | -300,00 | 27,39k | Verkauf | 91,30 | 1,19k | -20,09% |
| 2026-03-04 | Mr. Kumud KaliaChief Information Officer | 3,12k | 147,22k | Derivative Exercise and Retained Stock | 47,20 | 37,64k | 9,03% |
| 2026-03-04 | Mr. Kumud KaliaChief Information Officer | -40,00k | 2,34M | Derivative Exercise and Sale | 28,37 - 95,73 | 37,64k | - |
| 2026-02-28 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,05k | 0,81% |
| 2026-02-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,22k | 6,67% |
| 2026-02-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,49k | 18,40% |
| 2026-02-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,49k | 3,03% |
| 2026-01-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,90k | 0,82% |
| 2026-01-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,96k | 7,14% |
| 2026-01-21 | Ms. Terilyn Juarez MonroeCPO | -8,57k | 977,90k | Verkauf | 112,34 - 115,70 | 20,99k | -28,99% |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | -2,08M | 0,00 | Other Disposition | - | 2,43M | -46,13% |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -2,05M | 0,00 | Other Disposition | - | 2,39M | -46,15% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -47,92k | 0,00 | Other Disposition | - | 68,94k | -41,01% |
| 2026-01-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,26k | 22,55% |
| 2026-01-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,24k | 3,13% |
| 2026-01-15 | Ms. Terilyn Juarez MonroeCPO | 8,57k | 0,00 | Derivative Exercise and Retained Stock | - | 29,56k | 40,83% |
| 2026-01-15 | Ms. Terilyn Juarez MonroeCPO | -8,81k | 986,32k | Derivative Exercise and Sale | 111,98 | 29,56k | - |
| 2026-01-07 | Ms. Terilyn Juarez MonroeCPO | -10,03k | 1,12M | Verkauf | 111,75 - 113,44 | 20,99k | -32,34% |
| 2026-01-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 9,06k | 0,00 | Derivative Exercise and Retained Stock | - | 52,71k | 20,75% |
| 2026-01-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -9,99k | 1,02M | Derivative Exercise and Sale | 102,14 | 52,71k | - |
| 2026-01-01 | Ms. Terilyn Juarez MonroeCPO | 10,03k | 0,00 | Derivative Exercise and Retained Stock | - | 31,02k | 47,79% |
| 2026-01-01 | Ms. Terilyn Juarez MonroeCPO | -7,52k | 768,50k | Derivative Exercise and Sale | 102,14 | 31,02k | - |
| 2026-01-01 | Mr. Kumud KaliaChief Information Officer | 11,85k | 0,00 | Derivative Exercise and Retained Stock | - | 34,52k | 52,23% |
| 2026-01-01 | Mr. Kumud KaliaChief Information Officer | -9,39k | 959,30k | Derivative Exercise and Sale | 102,14 | 34,52k | - |
| 2026-01-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 17,08k | 0,00 | Derivative Exercise and Retained Stock | - | 43,87k | 63,72% |
| 2026-01-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -10,16k | 1,04M | Derivative Exercise and Sale | 102,14 | 43,87k | - |
| 2026-01-01 | Dr. Craig EagleInsider | 13,92k | 0,00 | Derivative Exercise and Retained Stock | - | 58,93k | 30,93% |
| 2026-01-01 | Dr. Craig EagleInsider | -11,52k | 1,18M | Derivative Exercise and Sale | 102,14 | 58,93k | - |
| 2026-01-01 | Dr. Darya ChudovaCTO | 10,42k | 0,00 | Derivative Exercise and Retained Stock | - | 71,91k | 16,94% |
| 2026-01-01 | Dr. Darya ChudovaCTO | -12,32k | 1,26M | Derivative Exercise and Sale | 102,14 | 71,91k | - |
| 2026-01-01 | Mr. Michael BellCFO | 10,56k | 0,00 | Derivative Exercise and Retained Stock | - | 40,22k | 35,59% |
| 2026-01-01 | Mr. Michael BellCFO | -12,48k | 1,27M | Derivative Exercise and Sale | 102,14 | 40,22k | - |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | 15,58k | 0,00 | Derivative Exercise and Retained Stock | - | 2,01M | 0,78% |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | -13,23k | 1,35M | Derivative Exercise and Sale | 102,14 | 2,01M | - |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 15,58k | 0,00 | Derivative Exercise and Retained Stock | - | 2,39M | 0,66% |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -13,23k | 1,35M | Derivative Exercise and Sale | 102,14 | 2,39M | - |
| 2025-12-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,75k | 0,83% |
| 2025-12-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 7,69% |
| 2025-12-17 | Mr. Musa TariqIndependent Director | -116,00 | 11,77k | Verkauf | 101,46 | 7,99k | -1,43% |
| 2025-12-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,03k | 29,11% |
| 2025-12-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,11k | 3,18% |
| 2025-12-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 485,00 | 0,00 | Derivative Exercise and Retained Stock | - | 43,66k | 1,12% |
| 2025-12-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535,00 | 54,93k | Derivative Exercise and Sale | 102,67 | 43,66k | - |
| 2025-12-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808,00 | 0,00 | Derivative Exercise and Retained Stock | - | 26,80k | 3,11% |
| 2025-12-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594,00 | 60,99k | Derivative Exercise and Sale | 102,67 | 26,80k | - |
| 2025-12-15 | Mr. Kumud KaliaChief Information Officer | 314,00 | 0,00 | Derivative Exercise and Retained Stock | - | 22,68k | 1,40% |
| 2025-12-15 | Mr. Kumud KaliaChief Information Officer | -323,00 | 33,16k | Derivative Exercise and Sale | 102,67 | 22,68k | - |
| 2025-12-15 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -90,57k | 9,40M | Verkauf | 103,80 - 104,02 | 2,38M | -3,67% |
| 2025-12-15 | Dr. Craig EagleInsider | 691,00 | 0,00 | Derivative Exercise and Retained Stock | - | 45,01k | 1,56% |
| 2025-12-15 | Dr. Craig EagleInsider | -711,00 | 73,00k | Derivative Exercise and Sale | 102,67 | 45,01k | - |
| 2025-12-15 | Dr. Darya ChudovaCTO | -5,45k | 567,13k | Verkauf | 104,04 | 61,49k | -8,14% |
| 2025-12-15 | Mr. Michael BellCFO | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 29,67k | 5,75% |
| 2025-12-15 | Mr. Michael BellCFO | -1,66k | 170,33k | Derivative Exercise and Sale | 102,67 | 29,67k | - |
| 2025-12-08 | Dr. AmirAli TalasazCo-CEO & Director | -387,95k | 0,00 | Other Disposition | - | 2,42M | -13,83% |
| 2025-12-08 | Dr. AmirAli TalasazCo-CEO & Director | -100,00k | 10,51M | Verkauf | 104,21 - 106,00 | 2,42M | -3,97% |
| 2025-12-08 | Mr. Kumud KaliaChief Information Officer | -2,00k | 209,20k | Verkauf | 104,60 | 22,37k | -8,21% |
| 2025-12-08 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 72,45k | Derivative Exercise and Sale | 32,55 - 105,00 | 797,00 | - |
| 2025-12-08 | Dr. Manuel Hidalgo MedinaIndependent Director | -250,00 | 26,25k | Verkauf | 105,00 | 797,00 | -23,88% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -22,94k | 2,42M | Verkauf | 105,04 - 106,00 | 66,94k | -25,52% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -68,14k | 0,00 | Other Disposition | - | 66,94k | -50,44% |
| 2025-12-05 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -31,45k | 3,24M | Verkauf | 101,40 - 106,71 | 25,99k | -54,76% |
| 2025-12-05 | Mr. Michael BellCFO | -56,29k | 4,07M | Derivative Exercise and Sale | 28,37 - 106,68 | 28,05k | - |
| 2025-12-05 | Mr. Michael BellCFO | -24,08k | 2,49M | Verkauf | 101,46 - 107,26 | 28,05k | -46,19% |
| 2025-12-05 | Mr. Ian T. ClarkLead Independent Director | -28,61k | 2,04M | Derivative Exercise and Sale | 31,84 - 108,05 | 9,85k | - |
| 2025-12-01 | Ms. Terilyn Juarez MonroeCPO | -50,00k | 4,16M | Derivative Exercise and Sale | 20,14 - 107,85 | 20,92k | - |
| 2025-12-01 | Ms. Terilyn Juarez MonroeCPO | -5,17k | 547,68k | Verkauf | 105,33 - 107,03 | 20,92k | -19,81% |
| 2025-11-30 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,59k | 0,84% |
| 2025-11-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,43k | 8,34% |
| 2025-11-19 | Mr. Musa TariqIndependent Director | -116,00 | 11,17k | Verkauf | 96,25 | 7,86k | -1,45% |
| 2025-11-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,05k | 28,47% |
| 2025-11-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,98k | 3,24% |
| 2025-11-07 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -9,00k | 865,87k | Verkauf | 96,25 | 43,17k | -17,24% |
| 2025-11-07 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 62,62k | Derivative Exercise and Sale | 32,55 - 95,17 | 815,00 | - |
| 2025-11-07 | Dr. Manuel Hidalgo MedinaIndependent Director | -500,00 | 47,62k | Verkauf | 95,23 | 815,00 | -38,02% |
| 2025-10-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,44k | 0,84% |
| 2025-10-21 | Mr. Roberto Agostino MignoneIndependent Director | 3,17k | 0,00 | Derivative Exercise and Retained Stock | - | 3,17k | - |
| 2025-10-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,32k | 21,42% |
| 2025-10-17 | Mr. Musa TariqIndependent Director | -116,00 | 7,77k | Verkauf | 66,95 | 7,73k | -1,48% |
| 2025-10-17 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,74k | Verkauf | 66,95 | 18,32k | -0,14% |
| 2025-10-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 6,74k | 0,00 | Derivative Exercise and Retained Stock | - | 52,17k | 14,83% |
| 2025-10-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -7,43k | 465,55k | Derivative Exercise and Sale | 62,65 | 52,17k | - |
| 2025-10-01 | Mr. Kumud KaliaChief Information Officer | 5,20k | 0,00 | Derivative Exercise and Retained Stock | - | 24,37k | 27,14% |
| 2025-10-01 | Mr. Kumud KaliaChief Information Officer | -5,35k | 335,05k | Derivative Exercise and Sale | 62,65 | 24,37k | - |
| 2025-10-01 | Ms. Terilyn Juarez MonroeCPO | 5,17k | 0,00 | Derivative Exercise and Retained Stock | - | 26,09k | 24,70% |
| 2025-10-01 | Ms. Terilyn Juarez MonroeCPO | -5,31k | 332,67k | Derivative Exercise and Sale | 62,65 | 26,09k | - |
| 2025-10-01 | Dr. Craig EagleInsider | 6,83k | 0,00 | Derivative Exercise and Retained Stock | - | 44,32k | 18,23% |
| 2025-10-01 | Dr. Craig EagleInsider | -7,03k | 440,12k | Derivative Exercise and Sale | 62,65 | 44,32k | - |
| 2025-10-01 | Dr. Darya ChudovaCTO | 7,94k | 0,00 | Derivative Exercise and Retained Stock | - | 89,39k | 9,75% |
| 2025-10-01 | Dr. Darya ChudovaCTO | -8,16k | 511,41k | Derivative Exercise and Sale | 62,65 | 89,39k | - |
| 2025-10-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 7,81k | 0,00 | Derivative Exercise and Retained Stock | - | 57,44k | 15,74% |
| 2025-10-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -5,74k | 359,61k | Derivative Exercise and Sale | 62,65 | 57,44k | - |
| 2025-09-30 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,28k | 0,85% |
| 2025-10-01 | Mr. Michael BellCFO | 7,49k | 0,00 | Derivative Exercise and Retained Stock | - | 52,13k | 16,77% |
| 2025-10-01 | Mr. Michael BellCFO | -7,70k | 482,09k | Derivative Exercise and Sale | 62,65 | 52,13k | - |
| 2025-09-30 | Dr. AmirAli TalasazCo-CEO & Director | 14,21k | 0,00 | Derivative Exercise and Retained Stock | - | 2,52M | 0,57% |
| 2025-09-30 | Dr. AmirAli TalasazCo-CEO & Director | -14,60k | 914,40k | Derivative Exercise and Sale | 62,48 - 62,65 | 2,52M | - |
| 2025-09-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 14,21k | 0,00 | Derivative Exercise and Retained Stock | - | 2,47M | 0,58% |
| 2025-09-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -14,60k | 914,40k | Derivative Exercise and Sale | 62,48 - 62,65 | 2,47M | - |
| 2025-09-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,08k | 27,26% |
| 2025-09-15 | Mr. Musa TariqIndependent Director | 133,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,59k | 1,78% |
| 2025-09-15 | Mr. Musa TariqIndependent Director | -116,00 | 6,45k | Derivative Exercise and Sale | 55,63 | 7,59k | - |
| 2025-09-15 | Ms. Myrtle S. PotterIndependent Director | 42,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,28k | 0,23% |
| 2025-09-15 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,45k | Derivative Exercise and Sale | 55,63 | 18,28k | - |
| 2025-09-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 484,00 | 0,00 | Derivative Exercise and Retained Stock | - | 45,43k | 1,08% |
| 2025-09-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535,00 | 29,31k | Derivative Exercise and Sale | 54,79 | 45,43k | - |
| 2025-09-15 | Mr. Kumud KaliaChief Information Officer | 314,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,16k | 1,67% |
| 2025-09-15 | Mr. Kumud KaliaChief Information Officer | -324,00 | 17,75k | Derivative Exercise and Sale | 54,79 | 19,16k | - |
| 2025-09-15 | Dr. Craig EagleInsider | 691,00 | 0,00 | Derivative Exercise and Retained Stock | - | 37,48k | 1,88% |
| 2025-09-15 | Dr. Craig EagleInsider | -711,00 | 38,96k | Derivative Exercise and Sale | 54,79 | 37,48k | - |
| 2025-09-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808,00 | 0,00 | Derivative Exercise and Retained Stock | - | 49,63k | 1,66% |
| 2025-09-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594,00 | 32,55k | Derivative Exercise and Sale | 54,79 | 49,63k | - |
| 2025-09-15 | Mr. Michael BellCFO | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 44,64k | 3,75% |
| 2025-09-15 | Mr. Michael BellCFO | -1,66k | 90,90k | Derivative Exercise and Sale | 54,79 | 44,64k | - |
| 2025-09-12 | Dr. Manuel Hidalgo MedinaIndependent Director | -2,17k | 117,25k | Verkauf | 54,16 | 851,00 | -71,78% |
| 2025-09-09 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -300,00k | 17,84M | Verkauf | 59,44 - 59,93 | 2,45M | -10,90% |
| 2025-09-02 | Ms. Meghan V. JoyceIndependent Director | -100,00 | 6,58k | Verkauf | 65,84 | 11,18k | -0,89% |
| 2025-09-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 125,00 | 0,00 | Derivative Exercise and Retained Stock | - | 44,95k | 0,28% |
| 2025-09-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -139,00 | 9,37k | Derivative Exercise and Sale | 67,42 | 44,95k | - |
| 2025-09-01 | Mr. Kumud KaliaChief Information Officer | 350,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,85k | 1,89% |
| 2025-09-01 | Mr. Kumud KaliaChief Information Officer | -361,00 | 24,34k | Derivative Exercise and Sale | 67,42 | 18,85k | - |
| 2025-09-01 | Dr. Darya ChudovaCTO | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 81,45k | 0,19% |
| 2025-09-01 | Dr. Darya ChudovaCTO | -161,00 | 10,85k | Derivative Exercise and Sale | 67,42 | 81,45k | - |
| 2025-08-31 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,13k | 0,86% |
| 2025-08-21 | Mr. Kumud KaliaChief Information Officer | -2,00k | 123,51k | Verkauf | 61,76 | 18,50k | -9,76% |
| 2025-08-19 | Mr. Musa TariqIndependent Director | -116,00 | 6,85k | Verkauf | 59,02 | 7,46k | -1,53% |
| 2025-08-19 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,53k | Verkauf | 59,02 | 18,24k | -0,14% |
| 2025-08-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,02k | 8,33% |
| 2025-08-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,57k | 3,41% |
| 2025-08-15 | Ms. Myrtle S. PotterIndependent Director | 69,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,27k | 0,38% |
| 2025-08-04 | Ms. Meghan V. JoyceIndependent Director | 67,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,28k | 0,60% |
| 2025-07-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 17,97k | 0,86% |
| 2025-07-17 | Mr. Musa TariqIndependent Director | -116,00 | 5,59k | Verkauf | 48,20 | 7,32k | -1,56% |
| 2025-07-17 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,25k | Verkauf | 48,20 | 18,20k | -0,14% |
| 2025-07-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 2,78k | 0,00 | Derivative Exercise and Retained Stock | - | 2,78k | - |
| 2025-07-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,44k | 3,48% |
| 2025-07-15 | Ms. Myrtle S. PotterIndependent Director | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,22k | 0,37% |
| 2025-07-04 | Ms. Meghan V. JoyceIndependent Director | 66,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,22k | 0,59% |
| 2025-07-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 1,26k | 0,00 | Derivative Exercise and Retained Stock | - | 44,82k | 2,88% |
| 2025-07-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -1,39k | 70,28k | Derivative Exercise and Sale | 50,71 | 44,82k | - |
| 2025-07-01 | Mr. Kumud KaliaChief Information Officer | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 20,50k | 6,92% |
| 2025-07-01 | Mr. Kumud KaliaChief Information Officer | -1,37k | 69,22k | Derivative Exercise and Sale | 50,71 | 20,50k | - |
| 2025-07-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 2,06k | 0,00 | Derivative Exercise and Retained Stock | - | 48,82k | 4,41% |
| 2025-07-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -1,53k | 77,69k | Derivative Exercise and Sale | 50,71 | 48,82k | - |
| 2025-07-01 | Dr. Craig EagleInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 36,79k | 4,75% |
| 2025-07-01 | Dr. Craig EagleInsider | -1,71k | 86,92k | Derivative Exercise and Sale | 50,71 | 36,79k | - |
| 2025-07-01 | Dr. Darya ChudovaCTO | 1,48k | 0,00 | Derivative Exercise and Retained Stock | - | 81,29k | 1,86% |
| 2025-07-01 | Dr. Darya ChudovaCTO | -1,53k | 77,33k | Derivative Exercise and Sale | 50,71 | 81,29k | - |
| 2025-07-01 | Mr. Michael BellCFO | 1,03k | 0,00 | Derivative Exercise and Retained Stock | - | 43,03k | 2,45% |
| 2025-07-01 | Mr. Michael BellCFO | -1,06k | 53,60k | Derivative Exercise and Sale | 50,71 | 43,03k | - |
| 2025-07-01 | Dr. AmirAli TalasazCo-CEO & Director | 24,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,50M | 0,97% |
| 2025-06-30 | Dr. AmirAli TalasazCo-CEO & Director | -4,82k | 247,32k | Derivative Exercise and Sale | 50,67 - 52,04 | 2,50M | - |
| 2025-07-01 | Dr. AmirAli TalasazCo-CEO & Director | -97,63k | 4,97M | Automatic Disposition | 50,67 - 51,40 | 2,50M | -3,75% |
| 2025-07-01 | Dr. AmirAli TalasazCo-CEO & Director | -12,16k | 616,74k | Sale to Issuer | 50,71 | 2,50M | -0,48% |
| 2025-06-30 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 17,82k | 0,87% |
| 2025-06-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 14,21k | 0,00 | Derivative Exercise and Retained Stock | - | 2,75M | 0,52% |
| 2025-06-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -14,60k | 743,76k | Derivative Exercise and Sale | 50,71 - 52,04 | 2,75M | - |
| 2025-06-18 | Mr. Musa TariqIndependent Director | -3,21k | 158,95k | Verkauf | 49,47 | 7,19k | -30,89% |
| 2025-06-18 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,29k | Verkauf | 49,47 | 18,15k | -0,14% |
| 2025-06-17 | Mr. Ian T. ClarkLead Independent Director | -6,67k | 322,82k | Verkauf | 48,38 | 9,85k | -40,38% |
| 2025-06-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 485,00 | 0,00 | Derivative Exercise and Retained Stock | - | 43,57k | 1,13% |
| 2025-06-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535,00 | 26,37k | Derivative Exercise and Sale | 49,29 | 43,57k | - |
| 2025-06-15 | Mr. Kumud KaliaChief Information Officer | 409,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,17k | 2,18% |
| 2025-06-15 | Mr. Kumud KaliaChief Information Officer | -228,00 | 11,24k | Derivative Exercise and Sale | 49,29 | 19,17k | - |
| 2025-06-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 3,61k | 0,00 | Derivative Exercise and Retained Stock | - | 46,76k | 8,36% |
| 2025-06-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -2,68k | 131,85k | Derivative Exercise and Sale | 49,29 | 46,76k | - |
| 2025-06-15 | Dr. Craig EagleInsider | 691,00 | 0,00 | Derivative Exercise and Retained Stock | - | 35,12k | 2,01% |
| 2025-06-15 | Dr. Craig EagleInsider | -711,00 | 35,05k | Derivative Exercise and Sale | 49,29 | 35,12k | - |
| 2025-06-15 | Mr. Michael BellCFO | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 42,00k | 3,99% |
| 2025-06-15 | Mr. Michael BellCFO | -1,66k | 81,77k | Derivative Exercise and Sale | 49,29 | 42,00k | - |
| 2025-06-12 | Ms. Myrtle S. PotterIndependent Director | 4,12k | 0,00 | Derivative Exercise and Retained Stock | - | 18,18k | 29,28% |
| 2025-06-12 | Ms. Myrtle S. PotterIndependent Director | -2,63k | 130,51k | Derivative Exercise and Sale | 49,70 | 18,18k | - |
| 2025-06-12 | Ms. Meghan V. JoyceIndependent Director | 3,34k | 0,00 | Derivative Exercise and Retained Stock | - | 11,15k | 42,71% |
| 2025-06-12 | Ms. Meghan V. JoyceIndependent Director | -3,34k | 157,57k | Derivative Exercise and Sale | 47,22 | 11,15k | - |
| 2025-06-12 | Mr. Musa TariqIndependent Director | 6,92k | 0,00 | Derivative Exercise and Retained Stock | - | 10,40k | 199,02% |
| 2025-06-12 | Mr. Steve Edward KrognesIndependent Director | 6,67k | 0,00 | Derivative Exercise and Retained Stock | - | 17,67k | 60,72% |
| 2025-06-12 | Ms. Vijaya GaddeIndependent Director | 6,67k | 0,00 | Derivative Exercise and Retained Stock | - | 24,31k | 37,83% |
| 2025-06-12 | Mr. Ian T. ClarkLead Independent Director | 8,09k | 0,00 | Derivative Exercise and Retained Stock | - | 16,52k | 95,89% |
| 2025-06-05 | Dr. AmirAli TalasazCo-CEO & Director | -119,28k | 5,97M | Automatic Disposition | 50,00 - 50,09 | 2,59M | -4,40% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
